Site enablement speeds studies and reduces costs according to new research

Clinical trial site enablement platforms can speed-up and reduce the cost of drug studies according to new research.

The research – by Marketcap Consulting – is based on interviews with clinical operations staff who use SiteLink, an enablement platform developed by Florence Healthcare.

And, according to the authors the tech accelerated study start-up by four weeks and study close-out by two weeks at every site.

For a 50-site study, they pointed out, this six-week acceleration reduced cash burn by one million dollars.

Site enablement technology prioritizes sites needs rather than sponsor experience. For example, the focus is on facilitating ease-of-use and ease-of-setup for the site.

The research findings are a clear indication of the benefits of enablement tech according to Joel White from Marketcap, who said “we can see a clear positive impact on study timelines and cash burn when research sponsors and CROs implement Site Enablement Platforms.

This early study reveals that by enabling sites to do their best work, the clinical research industry unlocks value across the full research cycle.”

Florence Healthcare CEO Ryan Jones welcomed the research, commenting that “pharma sponsors and CROs realize the importance of enabling sites to do their best work - but only recently have they discovered that traditional site portals are more hindrance than help.”

He also framed the findings as an endorsement of his firm’s technology, explaining that hitherto “organizations weren't able to measure the true impact of switching to a Site Enablement Platform.

This year-long study aimed to fix that and highlight how linking fragmented workflows accelerates the full lifecycle of clinical trials.”

Jones added that “while the financial impact of switching to SiteLink makes investing in site enablement an easy choice for sponsors and CROs, it’s really the acceleration of studies that gets our team at Florence Healthcare excited. We aim to double the output of research teams by the end of the decade, and enabling sites is the way to do it.”

Unsplash/CHUTTERSNAP